alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
11 TH COURT OF APPEALS

EASTLAND

, TEXAS

JUDGMENT

Hector Haro

, * From the 350 th District Court

of Taylor County,

Trial Court No. 15208

- D

.

Vs. No. 11

- 2 2

- 00 18 7

- CR * May 16 , 20 2 4

The State of Texas

, * Memorand um Opinion by Bailey

, C. J.

(P anel consists of: Bailey , C.J.,

Trotter , J. , and W illiams, J. )

This court has inspected the record in this cause and concludes that there is no

error in the judgment below. Therefore, in accordance with this court ’ s opi nion,

the judgment of the trial court is in all things affirmed.
#### § 660.3 Reference panel.

A Reference Hepatitis B Surface Antigen Panel shall be obtained from the Food and Drug Administration, Center for Biologics Evaluation and Research, Reagents and Standards Shipping, 10903 New Hampshire Ave., Bldg. 75, Rm. G704, Silver Spring, MD 20993-0002 and shall be used for determining the potency and specificity of Antibody to Hepatitis B Surface Antigen.

[40 FR 29711, July 15, 1975, as amended at 49 FR 23834, June 8, 1984; 55 FR 11013, Mar. 26, 1990; 70 FR 14985, Mar. 24, 2005; 80 FR 18093, Apr. 3, 2015]
# EUR-Lex - 31978R2116 - EN

Avis juridique important

*|*

# 31978R2116

**Commission Regulation (EEC) No 2116/78 of 7 September 1978 amending Regulation (EEC) No 2598/70 specifying the items to be included under the various headings in the forms of accounts shown in Annex I to Council Regulation (EEC) No 1108/70 of 4 June 1970 **

*
Official Journal L 246 , 08/09/1978 P. 0007 - 0008 Finnish special edition: Chapter 7 Volume 2 P. 0034 Greek special edition: Chapter 07 Volume 2 P. 0079 Swedish special edition: Chapter 7 Volume 2 P. 0034 Spanish special edition: Chapter 07 Volume 2 P. 0123 Portuguese special edition Chapter 07 Volume 2 P. 0123 *

COMMISSION REGULATION (EEC) No 2116/78 of 7 September 1978 amending Regulation (EEC) No 2598/70 specifying the items to be included under the various headings in the forms of accounts shown in Annex I to Council Regulation (EEC) No 1108/70 of 4 June 1970

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Economic Community,

Having regard to Council Regulation (EEC) No 1108/70 of 4 June 1970 introducing an accounting system for expenditure on infrastructure in respect of transport by rail, road and inland waterway (1), and in particular Article 9 (1) thereof,

Having regard to Commission Regulation (EEC) No 2598/70 of 18 December 1970 specifying the items to be included under the various headings in the forms of accounts shown in Annex I to Council Regulation (EEC) No 1108/70 of 4 June 1970 (2),

Having regard to the opinions expressed by members of the Committee of Government Experts,

Whereas the types of expenditure relating to rail infrastructures should be specified in order that the total of these expenditures as well as that part borne by the railway undertakings may be ascertained,

HAS ADOPTED THIS REGULATION:

Sole Article

Annex II to Regulation (EEC) No 2598/70 is amended in accordance with the Annex hereto.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 7 September 1978.

For the Commission

Richard BURKE

Member of the Commission (1)OJ No L 130, 15.6.1970, p. 4. (2)OJ No L 278, 23.12.1970, p. 1.

ANNEX Annex II to Regulation (EEC) No 2598/70 A. GENERAL OBSERVATIONS

The following is added to the second subparagraph of point 2:

"In the case of the railways, the amounts deducted are to be shown separately. Such amounts may relate in particular to compensation received in respect of: - infrastructure expenditure (Regulation (EEC) No 1107/70 (1), Article 3 (1) (b)),

- payments in respect of retirement and other pensions (Regulation (EEC) No 1192/69 (2), Article 4 (1) (c), Class III). (1)OJ No L 130, 15.6.1970, p. 1. (2)OJ No L 156, 28.6.1969, p. 8."
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM
THE BALANCE SHEET FOR DECEMBER 31, 1997 AND THE STATEMENT OF OPERATIONS
FOR THE YEAR ENDED DECEMBER 31, 1997 AND IS QUALIFIED IN ITS ENTIRETY
BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                       6,896,033
<SECURITIES>                                16,697,067
<RECEIVABLES>                               16,160,901
<ALLOWANCES>                                 2,619,485
<INVENTORY>                                    497,639
<CURRENT-ASSETS>                            40,868,294
<PP&E>                                      13,090,464
<DEPRECIATION>                               4,079,882
<TOTAL-ASSETS>                              54,452,119
<CURRENT-LIABILITIES>                        3,479,318
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       103,456
<OTHER-SE>                                  50,651,648
<TOTAL-LIABILITY-AND-EQUITY>                54,452,119
<SALES>                                              0
<TOTAL-REVENUES>                            32,951,514
<CGS>                                                0
<TOTAL-COSTS>                               12,574,164
<OTHER-EXPENSES>                            16,779,577
<LOSS-PROVISION>                             2,266,825
<INTEREST-EXPENSE>                             155,942
<INCOME-PRETAX>                              2,815,009
<INCOME-TAX>                               (1,437,172)
<INCOME-CONTINUING>                          4,252,181
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 4,252,181
<EPS-PRIMARY>                                     0.42
<EPS-DILUTED>                                     0.38


</TABLE>
Exhibit



Exhibit 10.1






January 30, 2017


Keith Westby 
Senior Vice President 
Dear Keith:
It is my pleasure to confirm your promotion to Senior Vice President & Chief Operating Officer effective January 30, 2017. You will report to Glenn Sblendorio, President & Chief Financial Officer. This position is exempt according to federal wage law, which means you will not be eligible for ovettime pay for hours worked in excess of 40 in a given work week.
Your annualized salary will  increase to $325,000 less taxes, effective January 30, 2017 and you will be classified as an Officer of the Company. Your bonus target will increase to 40%.
Keith, I congratulate you on this achievement and trust you will meet the challenges of your new position with great success. If you are in agreement with this letter, please sign and return a fully executed copy to me .


/s/ Amy Sheehan
Amy Sheehan 
Vice President, Human Resources




Accepted by: /s/ Keith Westby
Date: 2/1/17
#### State of Connecticut *v.*Louis Reed

*Louis Heed,*pro se, in support of the petition.

Submitted October 7

decided October 15, 1969

'The petition by the defendant for a writ of error coram nobis is dismissed.
#### Jerryl L. Keane *v.*John D. Cucurello et al.

*Allan B. Johnson,*on the motion.

*Jerryl L. Keane,*pro se, in opposition.

Submitted August 12

decided September 24, 1969

The motion by the defendants for review of the orders of July 25, 1969, of the Superior Court in Fairfield County waiving payment of fees, costs and security and directing a transcript be provided the plaintiff is granted, and those orders are vacated.
Exhibit 10.1


 


ONVIA 2017 MANAGEMENT INCENTIVE PLAN


 


Objectives


1. Align executive compensation with shareholder interests


2. Reward management for building shareholder value


3. Incentivize executives to drive key corporate initiatives


 


Participants 


President and CEO, CFO, CTO, SVP or Product, SVP of Marketing, VP of Human Resources


 


 


Structure of Plan


 


		1.	Three metrics for plan: bookings, EBITDA and individual objectives for each executive that support corporate objectives



		2.	The levels of bonus attainment are measured based on achievement of plan.



		3.	The three metrics are weighted as follows: Bookings (49%) and EBITDA (21%) and individual objectives (30%)



 


Plan Specifics


 


		1.	If bookings plan is met 100% of the target bonus is paid, below plan has a bookings floor to achieve 50% of target bonus, and
above plan potential for 200% of target bonus.



		2.	If EBITDA plan is met 100% of the target bonus is paid, below plan has an EBITDA floor to achieve 50% of target bonus, and
above plan potential for 130% of target bonus.









		3.	The individual objectives bonus becomes eligible based on achievement of the individual objectives up to 100% of target bonus.



		4.	If either EBITDA or bookings are below the floor, the corporate performance portion of the plan will not fund.
§ 74.302 Citrus Red No. 2. ( a ) *Identity.* ( 1 ) The color additive Citrus Red No. 2 is principally 1-(2,5-dimethoxyphenylazo)-2-naphthol.
( 2 ) The following diluents may be used in aqueous suspension, in the percentages specified, to facilitate application to oranges in accordance with paragraph (c)(1) of this section: ( i ) Suitable diluents used in accordance with § 73.1(a) of this chapter.
( ii ) Volatile solvents that leave no residue after application to the orange.
( iii ) Salts of fatty acids meeting the requirements of § 172.863 of this chapter.
( iv ) Sodium tripolyphosphate, not more than 0.05 percent.
( b ) *Specifications.* Citrus Red No. 2 shall conform to the following specifications and shall be free from impurities, other than those named, to the extent that such other impurities may be avoided by good manufacturing practice: Volatile matter (at 100 °C.), not more than 0.5 percent. Water-soluble matter, not more than 0.3 percent. Matter insoluble in carbon tetrachloride, not more than 0.5 percent. Uncombined intermediates, not more than 0.05 percent. Subsidiary dyes, not more than 2.0 percent. Lead (as Pb), not more than 10 parts per million. Arsenic (as As), not more than 1 part per million. Total color, not less than 98 percent.
( c ) *Uses and restrictions.* ( 1 ) Citrus Red No. 2 shall be used only for coloring the skins of oranges that are not intended or used for processing (or if so used are designated in the trade as *Packinghouse elimination*) and that meet minimum maturity standards established by or under the laws of the States in which the oranges are grown.
( 2 ) Oranges colored with Citrus Red No. 2 shall bear not more than 2.0 parts per million of such color additive, calculated on the basis of the weight of the whole fruit.
( d ) *Labeling.* The label of the color additive and any mixtures prepared therefrom and intended solely or in part for coloring purposes shall conform to the requirements of § 70.25 of this chapter. To meet the requirements of § 70.25 (b) and (c) of this chapter the label shall bear: ( 1 ) The statement (or its equivalent) “To be used only for coloring skins of oranges.”
( 2 ) Directions for use to limit the amount of the color additive to not more than 2.0 parts per million, calculated on the basis of the weight of the whole fruit.
( e ) *Certification.* All batches of Citrus Red No. 2 shall be certified in accordance with regulations in part 80 of this chapter.
Exhibit






Exhibit 10.25


[FORM OF]
FIRST AMENDMENT TO EMPLOYMENT AGREEMENT
(Farmer Bros. Co. / [Employee Last Name])
________________________________________________________
This First Amendment to Employment Agreement (“Amended Agreement”) is made and entered into as of May 3, 2017 between FARMER BROS. CO., a Delaware corporation (the “Company”), and [EMPLOYEE FULL NAME] (“[Employee Last Name]”), who agree as follows:
WHEREAS the Company and [Employee Last Name] are parties to an Employment Agreement (“Agreement”) dated [Date of Employment Agreement];
WHEREAS the parties desire to amend the Agreement to clarify certain rights and obligations of the parties to that Agreement;
The parties agree that the Agreement is amended to including the following paragraph:
Nothing contained in this Amended Agreement or the Agreement is intended to or shall be construed as prohibiting [Employee Last Name] from voluntarily communicating with the U.S. Securities and Exchange Commission (“Commission”) about possible violations of law or from accepting a Commission whistleblower award.
IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written.
COMPANY:                FARMER BROS. CO.,
a Delaware corporation




By:                        
Michael H. Keown
President and Chief Executive Officer




[EMPLOYEE FULL NAME]:
By:                        
[Employee Full Name]
Editorial Note on Part 73
Editorial Note: Nomenclature changes to part 73 appear at 66 FR 66742, Dec. 27, 2001.

§ 73.2496 Mica. ( a ) *Identity and specifications.* The color additive mica shall conform in identity and specifications to the requirements of § 73.1496(a)(1) and (b).
( b ) *Uses and restrictions.* Mica is safe for use in coloring cosmetics generally, including cosmetics applied to the area of the eye, in amounts consistent with good manufacturing practice.
( c ) *Labeling.* The color additive and any mixture prepared therefrom intended solely or in part for coloring purposes shall bear, in addition to any information required by law, labeling in accordance with of § 70.25 of this chapter.
( d ) *Exemption from certification.* Certification of this color additive is not necessary for the protection of the public health, and therefore batches thereof are exempt from the certification pursuant to section 721(c) of the act.
[42 FR 38561, July 29, 1977]
<Page>
                                               Exhibit 99.1

                   CERTIFICATION OF PERIODIC REPORT

I, Irving Levit, Chairman & CEO of Penn Treaty American Corporation, certify,
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section
1350, that:

    (1)  the Quarterly Report on Form 10-Q/A of the Company for the
         quarterly period ended September 30, 2002 (the ""Report'') fully
         complies with the requirements of Section 13(a) or 15(d) of the
         Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

    (2)  the information contained in the Report fairly presents, in all
         material respects, the financial condition and results of operations
         of the Company.

Dated: Dec. 24, 2002

                                          /s/ Irving Levit
                                          -----------------
                                          Irving Levit
                                          Chairman & CEO
<PAGE>

                                                                    Exhibit 99.1


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Annual Report of Avery Communications, Inc. (the
"Company") on Form 10-KSB for the period ending December 31, 2001 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
Patrick J. Haynes, III, Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

     (1) The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

     (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.


/s/ Patrick J. Haynes, III
------------------------------
Patrick J. Haynes, III
Chief Executive Officer
September 3, 2002
§ 640.24 Processing. ( a ) Separation of plasma and platelets and resuspension of the platelets must be in a closed system. Platelets must not be pooled during processing unless the platelets are pooled as specified in the directions for use for the blood collecting, processing, and storage system approved for such use by the Director, Center for Biologics Evaluation and Research.
( b ) Immediately after collection, the whole blood or plasma shall be held in storage between 20 and 24 °C unless it must be transported from the collection center to the processing laboratory. During such transport, all reasonable methods shall be used to maintain the temperature as close as possible to a range between 20 and 24 °C until it arrives at the processing laboratory where it shall be held between 20 and 24 °C until the platelets are separated. The platelet concentrate shall be separated within 4 hours or within the timeframe specified in the directions for use for the blood collecting, processing, and storage system.
( c ) The time and speed of centrifugation must have been demonstrated to produce an unclumped product, without visible hemolysis, that yields a count of not less than 5.5 × 1010 platelets per unit in at least 75 percent of the units tested.
( d ) The volume of original plasma used for resuspension of the platelets shall be determined by the maintenance of a pH of not less than 6.2 during the storage period. The pH shall be measured on a sample of platelets which has been stored for the maximum dating period at the selected storage temperature. One of the following storage temperatures shall be used continuously: ( 1 ) 20 to 24 °C.
( 2 ) 1 to 6 °C.
( e ) Final containers used for Platelets shall be colorless and transparent to permit visual inspection of the contents; any closure shall maintain a hermetic seal and prevent contamination of the contents. The container material shall not interact with the contents, under the customary conditions of storage and use, in such a manner as to have an adverse effect upon the safety, purity, potency, or efficacy of the product. At the time of filling, the final container shall be marked or identified by number so as to relate it to the donor.
[40 FR 4304, Jan. 29, 1975, as amended at 42 FR 10983, Feb. 25, 1977; 47 FR 49021, Oct. 29, 1982; 50 FR 4139, Jan. 29, 1985; 63 FR 16685, Apr. 6, 1998; 64 FR 45372, Aug. 19, 1999; 66 FR 1836, Jan. 10, 2001; 66 FR 40890, Aug. 6, 2001; 72 FR 45887, Aug. 16, 2007; 73 FR 7464, Feb. 8, 2008]
# Fourth Court of Appeals

San Antonio, Texas

October 19, 2018

No. 04

- 17

- 00316

- CV

LAREDO JET CENTER, LLC

,

Appellant

v.

CITY OF LAREDO

, Appellee

From the 341st Judicial District Court, Webb County, Texas

Trial Court No. 2016CVF003042D3

Honorable Rebecca Ramirez Palomo, Judge Presiding



### O R D E R

Sitting: Patricia O. Alvarez, Justice

Luz Elena D. Chapa, Justice

Irene Rios, Justice

A ppellant’s motion for rehearing is denied.

_________________________________ Luz Elena D. Chapa, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said

court on this 19th day of October, 20 18

.

___________________________________ KEITH E. HOTTLE

, Clerk of Court
<PAGE>   1
                                                                    EXHIBIT 23.1

                       CONSENT OF INDEPENDENT ACCOUNTANTS

      We hereby consent to the use in the Prospectus constituting part of this
Registration Statement on Form S-4 of ARIS Corporation of our report dated
January 28, 1999, except as to the pooling of interests with Barefoot Computer
Training Limited, which is as of February 28, 1998, relating to the financial
statements of ARIS Corporation, which appears in such Prospectus. We also
consent to the application of such report to the Financial Statement Schedule
for the three years ended December 31, 1998 when such schedule is read in
conjunction with the financial statements referred to in our report. The audits
referred to in such report also included this schedule. We also consent to the
references to PricewaterhouseCoopers LLP under the headings "Experts" and
"Selected Financial Data" in such Prospectus. However, it should be noted that
PricewaterhouseCoopers LLP has not prepared or certified such "Selected
Financial Data."


PricewaterhouseCoopers LLP
Seattle, Washington
August 3, 1999
Editorial Note on Part 73
Editorial Note: Nomenclature changes to part 73 appear at 66 FR 66742, Dec. 27, 2001.

§ 73.1200 Synthetic iron oxide. ( a ) *Identity.* ( 1 ) The color additive synthetic iron oxide consists of any one or any combination of synthetically prepared iron oxides, including the hydrated forms. It is free from admixture with other substances.
( 2 ) Color additive mixtures for drug use made with synthetic iron oxide may contain only those diluents listed in this subpart as safe and suitable in color additive mixtures for coloring drugs.
( b ) *Specifications.* Synthetic iron oxide shall conform to the following specifications, all on an “as is” basis: Arsenic (as As), not more than 3 parts per million. Lead (as Pb), not more than 10 parts per million. Mercury (as Hg), not more than 3 parts per million.
( c ) *Uses and restrictions.* The color additive synthetic iron oxide may be safely used to color ingested or topically applied drugs generally subject to the restriction that if the color additive is used in drugs ingested by man the amount consumed in accordance with labeled or prescribed dosages shall not exceed 5 milligrams, calculated as elemental iron, per day.
( d ) *Labeling requirements.* The label of the color additive and any mixtures intended solely or in part for coloring purposes prepared therefrom shall conform to the requirements of § 70.25 of this chapter.
( e ) *Exemption from certification.* Certification of this color additive is not necessary for the protection of the public health, and therefore batches thereof are exempt from certification requirements of section 721(c) of the act.
EXHIBIT 99.7


February 15, 2000

Moody's Investor Service
ABS Monitoring - Fourth Floor
99 Church Street
New York, NY 10007

Fitch IBCA, Inc.
One State Street Plaza
New York, NY 10004

Standard & Poor's Corporation
ABS Surveillance: Credit Cards
55 Water Street
New York, NY 10041

Bankers Trust Company
4 Albany Street
New York, NY 10006


                          UNIVERSAL CARD SERVICES CORP.

         The undersigned, a duly authorized representative of Universal Card
Services Corp., as Servicer ("UCS"), pursuant to the Amended and Restated
Pooling and Servicing Agreement dated as of April 24, 1998 (as amended and
supplemented, the "Agreement"), among Universal Bank, National Association, as
Transferor, UCS, and Bankers Trust Company, as Trustee, does hereby certify
that:

         1. UCS is, as of the date hereof, the Servicer under the Agreement.
Capitalized terms used in this Certificate have their respective meanings as set
forth in the Agreement.

         2. The undersigned is a Servicing Officer who is duly authorized
pursuant to the Agreement to execute and deliver this Certificate to the
Trustee.

         3. A review of the activities of the Servicer during the year ended
December 31, 1999, and of its performance under the Agreement was conducted
under my supervision.

         4. Based on such review, the Servicer has, to the best of my knowledge,
performed in all material respects its obligations under the Agreement
throughout such year and no default in the performance of such obligations has
occurred or is continuing.

         IN WITNESS WHEREOF, the undersigned has duly executed this Certificate
as of the date first written above.


                              UNIVERSAL CARD SERVICES CORP.,
                                as Servicer,


                              By  /s/    Andrew Lubliner
                                  -----------------------
                                  Name:  Andrew Lubliner
                                  Title: Servicing Officer